← All Posts
CAP
CAPRICOR THERAPEUTICS, INC.
June 05, 2026
•
Author: Phil Ratcliff
•
CAPR
| Item |
Proposal |
Vote |
| 1 |
To elect the eight (8) nominees named in this proxy statement to the Company’s board of directors to serve for a one-year term expiring at our 2027 Annual Meeting of Stockholders; |
|
| 1.1 |
Linda Marbán, Ph.D. |
✗ Against(61)
|
| 1.2 |
Frank Litvack, M.D., FACC |
✓ For(61)
|
| 1.3 |
David B. Musket |
✓ For(61)
|
| 1.4 |
George W. Dunbar Jr., M.B.A. |
✓ For(61)
|
| 1.5 |
Karimah Es Sabar |
✓ For(61)
|
| 1.6 |
Paul Auwaerter, M.D., M.B.A. |
✓ For(61)
|
| 1.7 |
Philip Gotwals, Ph.D. |
✓ For(61)
|
| 1.8 |
Michael Kelliher |
✓ For(61)
|
| 2 |
To ratify the appointment of Rose, Snyder & Jacobs LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; |
✓ For(61)
|
| 3 |
To approve, by non-binding advisory vote, the resolution approving named executive officer compensation; |
✓ For(61)
|
| 4 |
To approve a non-binding resolution on the frequency of future votes on our named executive officer compensation; |
1 Year
|
| 5 |
To consider and act upon approval of an amendment to the Certificate of Incorporation regarding officer exculpation; |
✓ For(61)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial